GE HealthCare price target raised to $97 from $95 at Piper Sandler

Piper Sandler raised the firm’s price target on GE HealthCare (GEHC) to $97 from $95 and keeps an Overweight rating on the shares. The firm notes GE HealthCare reported Q3 results, with revenue and EPS of $4,863M and $1.14 vs. the Street’s $4.868B and $1.05, while orders grew 1% as strength in the U.S. supported the operational performance in the quarter. Full-year guidance was adjusted to reflect Q3 dynamics, while the recent revenue sluggishness in the China market tied to slow stimulus funding coordination appears likely to bleed into the first half of 2025. For the stock, Piper sees the modest positive reaction as a relief that results, guidance, and 2025 commentary were less concerning than feared.